Aprea Therapeutics (NasdaqCM:APRE) FY Conference Transcript

Aprea Therapeutics (NasdaqCM:APRE) FY Conference September 09, 2025 03:30 PM ET Speaker0On that note, good afternoon, everyone, and welcome to our next session. I'm your moderator, Sara Nick. I'm an equity research VP at HC Wainwright, and it's my pleasure to introduce our next presenter, Aurin Gilad, CEO at Apraya Therapeutics, a biopharmaceutical company developing small molecule inhibitors to exploit genetic mutations in cancer. With that, the floor is yours, Aurin.Speaker1Thank you. Thank you, Sarah, fo ...